Efthimios Sivridis
Overview
Explore the profile of Efthimios Sivridis including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
159
Citations
8399
Followers
0
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Koukourakis M, Giatromanolaki A, Zois C, Kalamida D, Pouliliou S, Karagounis I, et al.
Sci Rep
. 2025 Feb;
15(1):4069.
PMID: 39900942
No abstract available.
2.
Lamprou I, Kakouratos C, Tsolou A, Pavlidis P, Xanthopoulou E, Nanos C, et al.
Int J Radiat Oncol Biol Phys
. 2022 Feb;
113(2):401-414.
PMID: 35121129
Purpose: Radiation therapy is a principal treatment modality for localized and locally advanced prostate cancer (PCa). Metabolic alterations, including lipid metabolism, may reduce treatment efficacy, resulting in tumor relapse and...
3.
Sivridis E, Kouroupi M, Koukourakis M, Arelaki S, Lyratzopoulos N, Giatromanolaki A
J Med Case Rep
. 2019 May;
13(1):159.
PMID: 31133043
Background: The rheumatoid nodule is the most common extra-articular manifestation of rheumatoid arthritis. When present, it is readily identified in conventional hematoxylin and eosin sections. Case Presentation: We report a...
4.
Sivridis E, Koukourakis I, Arelaki S, Balaska K, Karpouzis A, Giatromanolaki A
Head Neck Pathol
. 2019 Apr;
14(1):150-155.
PMID: 30977096
To investigate the expression patterns of autophagy marker light chain protein 3 (LC3A) in keratoacanthoma (KA). KAs are generally regarded as benign but malignant behavior, including rare metastases, may occur....
5.
Giatromanolaki A, Koukourakis M, Georgiou I, Kouroupi M, Sivridis E
Anticancer Res
. 2018 Dec;
38(12):6827-6833.
PMID: 30504397
Background: The current study examined the key proteins involved in autophagosome formation and their prognostic role in gastric cancer. Materials And Methods: Paraffin-embedded tissues from 121 consecutive patients treated with...
6.
Koukourakis M, Kontomanolis E, Sotiropoulou M, Mitrakas A, Dafa E, Pouliliou S, et al.
Anticancer Res
. 2018 Oct;
38(10):5739-5745.
PMID: 30275195
Background: Recently, programmed cell death protein 1 (PD1) blocking and anti-programmed death-ligand 1 (PD-L1) agents were approved for the treatment of various human malignancies. Materials And Methods: Our study examined...
7.
Arelaki S, Arampatzioglou A, Kambas K, Sivridis E, Giatromanolaki A, Ritis K
PLoS One
. 2018 Mar;
13(3):e0193089.
PMID: 29543850
Inflammation is a hallmark of colorectal cancer (CRC). Neutrophils are well-known mediators in tumor biology but their role in solid tumors, including CRC, was redefined by neutrophil extracellular traps (NETs)....
8.
Koukourakis M, Giatromanolaki A, Fylaktakidou K, Sivridis E, Zois C, Kalamida D, et al.
Invest New Drugs
. 2018 Feb;
36(5):773-781.
PMID: 29387992
Effective cytoprotectors that are selective for normal tissues could decrease radiotherapy and chemotherapy sequelae and facilitate the safe administration of higher radiation doses. This could improve the cure rates of...
9.
Giatromanolaki A, Balaska K, Kalamida D, Kakouratos C, Sivridis E, Koukourakis M
Cancer Biol Med
. 2018 Jan;
14(4):396-404.
PMID: 29372106
Uncoupling protein 1 (UCP1) is a proton transporter/channel residing on the inner mitochondrial membrane and is involved in cellular heat production. Using immunohistochemistry, we investigated the expression of UCP1 and...
10.
Koukourakis M, Giatromanolaki A, Fylaktakidou K, Kouroupi M, Sivridis E, Zois C, et al.
Anticancer Res
. 2017 Dec;
38(1):227-238.
PMID: 29277777
Background/aim: Amifostine is the only selective normal tissue cytoprotector, approved for the protection against platinum toxicities and radiotherapy-induced xerostomia. Free radical scavenger and DNA repair activities have been attributed to...